GYRE
Gyre Therapeutics Inc.
Company Overview
| Mkt Cap | $786.88M | Price | $7.75 |
| Volume | 36.24K | Change | +1.31% |
| P/E Ratio | 65.1 | Open | $7.61 |
| Revenue | $105.8M | Prev Close | $7.65 |
| Net Income | $12.1M | 52W Range | $6.11 - $19.00 |
| Div Yield | N/A | Target | $18.00 |
| Overall | 30 | Value | 20 |
| Quality | 52 | Technical | 18 |
No chart data available
Stock Overview
Updated DailyGyre Therapeutics Inc. (GYRE) is a leading diversified company in the business industry, currently trading at $7.75 with a market capitalization of $786.88 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating average quality indicators with a MarketXLS quality score of 52.
Today's trading session shows GYRE with a volume of 36K shares. The stock opened down 0.52% from yesterday's close of $7.65. Current analyst estimates project earnings of $0.13 per share for this year, with next year targeting $0.28.
GYRE demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange.
Key investment considerations for GYRE include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 132.3%. The stock shows expensive valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:18 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GYRE | $7.75 | +1.3% | 36.24K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |